The U1 snRNP-specific protein C contains an N-terminal zinc finger-like CH motif which Is required for the binding of the U1C protein to the U1 snRNP particle. Recently a similar motif was reported to be essential for In vivo homodimerization of the yeast splicing factor PRP9. In the present study we demonstrate that the human U1C protein is able to form homodimers as well. U1C homodimers are found when (i) the human U1C protein is expressed in Escherlchia coll, (II) immunoprecipitations with anti-U1C antibodies are performed on in vitro translated U1C, and when (iii) the yeast two hybrid system Is used. Analyses of mutant U1C proteins in an in vitro dimerization assay and the yeast two hybrid system revealed that amlno acids within the CH motif, i.e. between positions 22 and 30, are required for homodimerization.
INTRODUCTION
During the process of pre-mRNA splicing, the UI snRNP particle binds to the 5' splice site of the pre-mRNA resulting in the formation of a commitment complex (I). In addition to the so-called common or Sm proteins (2) which are also present in the U2, U4 and U5 snRNPs, Ul snRNP contains three specific proteins denoted UI-70K, UIA and UIC (2, 3) . For its activity in splicing both the Ul RNA and protein, components are known to be needed but the precise function in the splicing process of the latter is only poorly understood (I-5). Recently it was shown by in vitro studies that the UI-70K protein plays an essential role in splicing, a role in which the phosphorylation state of the protein appears to be crucial (6) .
With regard to the U1C protein, Heinrichs and co-workers (7) performed a functional study in which the pre-mRNA binding capacity of Ul snRNP particles containing or lacking the UlC protein was compared in an in vitro assay. Ul snRNPs lacking the UlC protein bound to the pre-mRNA 5' splice site with only 40% efficiency as compared with complete Ul snRNPs. Binding efficiency could be restored to wild-type levels by adding purified HeLa UlC protein. These results suggested that the UlC protein is involved in the binding of the UI snRNP particle to the 5' splice site.
In contrast with the U1-70K and UlA protein, the UlC protein does not contain an RNP-80 or RNA recognition motif (8) . Lacking such a motif, the UlC protein can only bind to the UI snRNP particle when the U1-70K and common proteins are already associated with the UI RNA (9) . The N-terminal region of UlC, containing a zinc finger-like sequence which resembles the CC-HH zinc fingers of the TFIIIa type, is required and sufficient for this interaction (10) . Similar CH motifs have been observed in the yeast splicing proteins PRP6, PRP9 and PRPll (11, 12) . Neither one of the proteins UlC, PRP6, PRP9 or PRPll, however, has actually been shown to bind zinc. Recently, Legrain and co-workers (13) demonstrated in the yeast two hybrid system that the two CH motifs in the PRP9 protein are required for the formation of PRP9 homodimers.
In the present study we show that the human U1C protein is able to form homodimers as well. UlC dimers were detected in preparations of human U1C protein expressed in Escherichia coli and dimerization could be induced with in vitro translated UlC. In both an in vitro dimerization assay and the yeast two hybrid system it could be demonstrated that amino acid residues between positions 22 and 30 are required for dimerization.
MATERIALS AND METHODS

Expression and purification of (his)6-tagged human UlC protein in E.coli
Using site directed mutagenesis an Nde\ site was introduced at the translational start codon of the human UlC cDNA, which was cloned into pGEM-3Zf(+). By PCR the translational stop codon of the (AWel)UlC cDNA was replaced by the codons of six histidine residues, followed by a stop codon and a BamHl site. Subsequently the UlC(his)6 cDNA was recloned as an Nde\-BamH\ fragment into the expression vector pET-3b (14) and with this construct E.coli strain BL21(DE3)pLysS (15) was transformed. The human UlC(his) 0 protein was overexpressed (16), followed by freeze-thawing and sonication of the cells in 10 ml PBS with 0.5 mM PMSF, 10 mM MgCb and 0.5 mg DNAse I. After centrifugation all U1 C(his)6 was present in the non-soluble fraction which could be dissolved in 8 M urea. In the text the solubilized UlC(his) 0 fraction is referred to as UlC(his)6 bacterial extract A control extract was prepared from BL21(DE3)pLysS transformed with pET-3b lacking the U1C cDNA.
The UlC(his)6 protein was purified from the bacterial extract following the procedures described by Janknecht et al. (17) and Schmitt et al. (18) . UlC(his)6 bacterial extract was incubated batchwise at 20°C with Ni-NTA-agarose beads (Qiagen) and IPPlco (10 mM Tris-HCl pH 8.0; 100 raM NaCl; 0.05% NP-40). Proteins bound to the Ni-groups were eluted batchwise by incubating the beads two times during 5 min with elution buffer D [ 10 mM HEPES pH 7.9; 5 mM MgCl 2 ; 0.1 mM EDTA; 50 mM NaCl; 17% glycerol (v/v); 1 mM DTE; 1 mM PMSF; 10 mM NaF] containing increasing concentrations of imidazole: 40 mM, 60 mM, 200 mM, 500 mM. When the purification was performed under non-reducing conditions, DTE was omitted from the elution buffer.
Site directed mutagenesis
Single-stranded DNA of the U1C cDNA cloned into pGEM-3Zf(+) was produced with the helper phage M13K07. Point mutations were introduced into the cDNA using the oligo-directed mutagenesis system kit from Amersham and checked by sequencing.
In vitro transcription and translation
To produce T7-U1C mRNA for translation, 1 \ig of linearized template was transcribed in essentially the same manner as described by Scherly et al. (19) . The cDNA encoding U1C was recloned in pGEM-3Zf(+)(Promega) lacking a functional Bam\\\ site, as described previously (10) . To produce 35 S-labeled U1C protein or derivatives thereof, 200 ng (2 (il) of the corresponding T7-mRNA were incubated with wheat germ extract (Amersham) and 35 S-methionine (Amersham) in essentially the same manner as described by Scherly et al. (19) .
Truncated C proteins
To produce templates for the truncated human U1C proteins containing amino acids 23-159 and 30-159, the codons for residues 21/22 or 28/29 in the U1C cDNA were replaced by a BamHl site (contains codons for Gly and Ser) using the site directed mutagenesis technique. The U1C sequences coding for residues 23-159 and 30-159 respectively, were subcloned as BamHl-HindBl fragments directly behind the start codon of the mutant U1A (2/3) construct, in which codons for residues 2 and 3 were replaced by a BamH\ site (20) . Except for the Ul A start codon the new U1C constructs do not contain any other U1A codons.
In vitro U1C dimerization assay
UlC(his)6 containing bacterial extract (15 |il) was incubated for 1 h at 20°C with 20 \i\ Ni-NTA-agarose (50% slurry) and 30 nl IPPl50-The beads were washed three times with 0. was added to the assay also more 35 S-labeled U1C could be precipitated (data not shown). The elution fractions were separated on an SDS-polyacrylamide gel. When separation was performed under non-reducing conditions the fi-mercaptoethanol (5%) was omitted from the sample buffer.
Immunodetection of Ul snRNP proteins on Western blot
Ul snRNP proteins transferred to nitrocellulose were detected by immunostaining with monoclonal (mouse) and monospecific (rabbit) antibodies specifically directed against U1 snRNP proteins, and with phosphatase-conjugated second antibodies as described by Lehmeier et al. (21) . The monoclonal mouse antibodies used were directed against the U1-70K (H111) (22) , U1A (9A9) (23), B/B' (KSm5) and Dl (KSm2) (24) proteins. Monospecific rabbit antibodies specifically raised against a peptide or recombinant fragment of the respective antigen, were used to detect the U1C, D3, D2, F and G (25) protein. Anti-(his)6 antibodies were raised by immunizing a rabbit with (his)g coupled to BSA (EuroDiagnostica B.V., Apeldoom, The Netherlands). The anti-(his)6-tag antibodies do recognize U lC(his)6 protein but not U1C protein lacking the (his)6-tag.
Detection of U1C homodimers using the yeast two hybrid system
Cloning of the Ul Cfusion proteins. A cloned human U1C cDN A (26) was used as a template for PCR amplification with different primers. The resulting DNA fragments encode the wild-type U1C protein or various N-terminal deletion mutants [corresponding to U1C(63-159), U1C(23-159) and U1C(3O-159); see Fig. 4A ]. These DNAs were cloned in the pAS2 plasmid, allowing syndiesis of corresponding fusion proteins with the Gal4 DNA binding domain (Gal4BD). The wild-type amplified DNA fragment was also cloned in the pACTII plasmid for production of fusion protein with the Gal4 activator domain (Gal4AD; 27,28). Sequences of PCR amplified fragments were verified.
Yeast manipulations. Yeast cells were grown and transformed according to standard procedures. The Y526 yeast strain {MAT&, his3~, ade2~, Iys2~, trpl~, Ieu2~, canR, gal4~, gal80~, URA::GALl-lacZ) was transformed with the two plasmids and transformants were selected on minimal medium lacking leucine and tryptophan and assayed for pVgalactosidase activity using a filter assay with X-gal. Several colonies were streaked and cells were grown in liquid cultures to perform quantitative fi-galactosidase assays (13) .
RESULTS
Expression and functionality of recombinant UlC(his)g protein
To investigate whether U1C is able to form homodimers, the human U1C protein with a C-terminal tag of six histidine residues, was expressed in E.coli. The expressed UlC(his)6 protein was detected on a Coommassie Brilliant Blue stained SDS-polyacrylamide gel as a prominent 21 kD band, which was not present in a control extract of bacteria lacking UlC(his)6. This 21 kD band corresponds with the expected mobility of the UIC protein from HeLa cells (26) and is immunologically recognized on a Western blot by anti-UlC monospecific antibodies directed to the CH motif of the protein and by anti-(his)6 polyclonal antibodies (data not shown). Both antibodies did not crossreact with bacterial proteins. Interestingly, a band of -42 kD was also detected with both antibodies. The characterization of this band will be discussed below.
The UlC(his)6 protein was purified from the extract with Ni-NTA-agarose. Proteins bound to the Ni-NTA-groups were specifically eluted with increasing imidazole concentrations. The UlC(his)6 protein was eluted most efficiently at a concentration of 200 mM imidazole (data not shown). The purified UlC(his)6 protein seems to be functional since it is capable of competing with in vitro translated 35 S-labeled U1C protein for binding to U1 snRNPs (data not shown) in an SI00 reconstitution assay as described previously (10) .
Recombinant human U1C protein is able to form homodimers
Based on the immunostaining of a42 kD band as described above, we hypothesized that the 42 kD complex might represent a UlC(his)6 homodimer. To detect the putative UlC(his)6 dimer band on a Coomassie stained gel as well, the purification with Ni-NTA-agarose was repeated under non-reducing conditions, i.e. without DTE in the bacterial extract and elution buffers. Subsequently, samples of the elution fractions were separated under non-reducing conditions, i.e. p-mercaptoethanol was omitted from the sample buffer, on an SDS-polyacrylamide gel ( Fig. 1 A) . Following this procedure -90% of the UlC(his)6 in the bacterial extract was retained on the Ni-NTA-agarose beads (compare lanes 2 and 3). Most of the eluted UlC(his)6 is present in the 200 mM imidazole elution fraction (lane 6) but at 500 mM imidazole a considerable amount of U1 C(his)6 was eluted as well (lane 7). The bands which migrate at -12 and 16 kD most likely represent distinct U1C degradation products. Figure 1A (lanes 5-7) demonstrates that under non-reducing conditions the putative UlC(his)6 homodimer of 42 kD indeed can be detected on a Coomassie stained gel. The finding that this band is only present in the imidazole eluted protein preparation under non-reducing conditions suggests that the 42 kD band corresponds to a complex of proteins held together by one or more disulfide bridges.
To provide more evidence for the presence of the UlC(his)6 protein in the 42 kD complex, UlC(his)6 bacterial extract was separated on an SDS-polyacrylamide gel under non-reducing conditions. As a control, bacterial extract lacking UlC(his)6 was separated on the same gel. With reference to the markers a gel piece from the lanes of both extracts was cut out of the gel at the position of the 42 kD band and extracted with standard reducing SDS-sample buffer. Both samples were separated on an SDSpolyacrylamide gel and Western blotted. Figure IB shows the Western blot immunostained with monospecific antibodies directed to the U1C protein. With antibodies directed to the (his)6-tag similar results were obtained (not shown). In the control lane (lane 1) no proteins were detected with anti-U 1C antibodies. The 42 kD complex from the UlC(his)(j bacterial extract, however, could partly be reduced to UlC(his)6 monomers, migrating at 21 kD (Fig. 1B, lane 2) . A similar result was obtained when purified, non-reduced UlC(his)6 (200 mM imidazole elution fraction; Fig. 1 A, lane 6) was pre-incubated with 25 mM DTE and separated by SDS-PAGE in the presence of DTE (data not shown). These results indicate that the UlC(his)6 protein expressed in E.coli indeed is able to form homodimers, which might be stabilized by one ore more disulfide bridges. Apparently not all of the U1 C(his)6 dimers were reduced in the experiment of Figure 1B since the 42 kD band still could be detected. This may be due to the relatively high concentration of the recombinant U1C protein or limited accessibility of a disulfide bridge.
In vitro translated U1C forms homodimers as well
In order to test whether U1C homodimers also can be detected when the protein is synthesized in vitro we immunoprecipitated 35 S-labeled U1C translated in wheat germ extract using polyclonal anti-U 1C antibodies. was used (Fig. 2, lane 4) . The dimer from the in vitro UlC translation migrates somewhat faster than the dimer generated in the dimerization assay (Fig. 2, compare lanes 3 and 4) because the in vitro translated protein lacks a (his)6-tag. No dimers were observed when the UlC translation mixture was separated by non-reducing SDS-PAGE (Fig. 2, lane 2) .
The dimerization assay
An in vitro dimerization assay was developed in which the dimerization between UlC(his)6 expressed in E.coli and in vitro translated 35 S-labeled UlC could be analyzed in more detail (Fig.  3A) .
In this assay, UlC(his)6 from a bacterial extract was coupled to Ni-NTA-agarose beads. All non-bound proteins were removed by extensive washing of the beads. Based on the results obtained by SDS-PAGE analyses shown above we can assume that UlC(his)6 is present on the Ni-beads as a mixture of monomers and dimers. The UlC(his)6-Ni-beads were then incubated with in vitro translated 35 S-labeled human UlC protein lacking a (his)6-tag. Following several wash steps the bound UI C(his)6 and the 35 S-labeled UlC associated with it, were specifically eluted by 200 mM imidazole. As a negative control the 35 S-labeled U1C was added to Ni-NTA-agarose beads pre-incubated with bacterial extract lacking UlC(his>6.
One sample of each elution fraction was analyzed on a standard reducing SDS-polyacrylamide gel, another sample on a non-reducing gel, i.e. in the absence of p-mercaptoethanol. Figure 3B , lane 2 demonstrates that a 35 S-labeled protein(complex) of -41 kD is eluted in the absence of a reducing agent. Since the 41 kD band was never observed in the control assays (lanes 3 and 5) it is most likely to conclude that the 41 kD complex corresponds to a dimer formed by UlC(his)6 and 35 S-labeled UIC [this dimer thus migrates somewhat faster than the 42 kD UIC(his) 6 
Amino acids between positions 22 and 30 are required for homodimerization
To determine which part of the UlC protein is involved in dimer formation 35 S-labeled U1C mutant proteins (Fig. 4A) were tested in the in vitro dimerization assay. The mutant U1C(1-6O) is S-labeled mutant U1C protein in the dimerization assay the 200 raM imidazole elution fraction was analyzed on an SDS-polyacrylamide gel under non-reducing conditions. Wild-type U1C protein was included as a positive control (Fig. 4B) .
The U1C(1-6O) protein seems to dimerize with UlC(his)6 almost as efficient as the wild-type protein. The N-terminal domain, containing the zinc finger-like region thus appears to be sufficient for in vitro dimerization. Further analyses of N-terminal deletion mutants show that the first 22 amino acids, which encompass the two conserved cysteines of the zinc finger-like region, are not essential for dimerization. The mutant protein U1C(23-159) still is able to dimerize with UlC(his)6 whereas UlC(30-159) has completely lost its ability to interact with UlC(his) 6 [ Fig. 4B , lanes 2 of (23-159) and (30-159)]. All the mutations which previously were shown to abolish binding to U1 snRNP hardly or only moderately interfered with dimerization in this assay [ Fig. 4B , lanes 2 of (s21/22), (s24), (s30)]. When Cys-25 is substituted, no stable dimers can be detected after SDS-PAGE (Fig. 4B, lane 2 of s25) , indicating that Cys-25 is most likely the residue responsible for disulfide bridge formation between two U1C proteins. However, as for all dimerizing U1C derivates, incubation of mutant s25 leads to a specific monomeric signal (Fig. 4B, lanes 2) . These results suggest that s25 is able to form homodimers purely as a result of non-covalent interactions which are disrupted during SDS-PAGE.
The N-terminal deletion mutant U1 C(23-l 59) for some reason gives a higher monomer background in the dimerization assay. At the moment we have no explanation for this phenomenon.
Similar results were obtained when in vitro translated known to bind to U1 snRNP with comparable efficiency as the wild-type protein (9) . The U1C substitution mutants (s24) and (s30), in which a histidine residue is substituted by a glutamine, were previously reported to have lost their ability to bind to Ul
U1C homodimers are detected in the yeast two hybrid assay
To verify the results of our in vitro assays, we used the two hybrid assay in yeast which allows the detection of protein-protein interactions in vivo (29) . When the two U1C wild-type fusion proteins were expressed in yeast, P-galactosidase activity was detected using a qualitative X-gal conversion assay (data not shown). This was specific since the production of any of the two fusion proteins in combination with an irrelevant protein did not induce fJ-galactosidase synthesis. However, transformants grew slowly and, when primary transformants were streaked on plates, fast growing variants were often recovered which were systematically negative in an X-gal conversion assay.
To analyze the formation of U1C protein homodimers in more detail, several versions of the U1C protein fused to the Gal4 DNA binding domain were assayed in combination with the wild-type U1C partner fused to the Gal4 activation domain. In Figure 5 it is shown that dimers are formed between wild-type and U1C(23-159) proteins and resulting P-galactosidase activities are comparable or even higher than those detected for the wild-type homodimer. The various clones exhibited different activities, Figure 5 . Analysis of U1C dimers in the yeast two hybrid assay. Fusion proteins expressed by the cells are indicated below the histograms (Gal4AD fusion protein/Gal4BD fusion protein). Five independent transformants were streaked for each experiment. PRP21 is a yeast splicing factor (28) . Assays were done in duplicate for each transformant and the values were within a 10% variation range.
probably reflecting a variable amount of negative variants arising during the liquid culture. When the wild-type U1C fused to the GAM activation domain was replaced by an irrelevant protein such as PRP21, no P-galactosidase activity was observed indicating that the activity measured for the combination of the wild-type U1C and the U1C(23-159) proteins very likely reflects the formation of a dimer. Similarly, the co-expression of the wild-type U1C protein in combination with U1C(3O-159), U1C(63-159) or an irrelevant protein did not lead to any detectable (j-galactosidase activity. A number of U1C point mutants (s6, s9, s24, s25 and s30) were tested in the yeast two hybrid assay as well. These mutants also showed dimer formation in vivo (data not shown). Our results suggest that in the yeast two hybrid system non-covalent interactions are sufficient for U1C dimerization. We conclude that in the two hybrid assay U1C homodimers are detected and that their assembly points to a functional region between the amino acid residues 22 and 30, which is in agreement with the results obtained with our dimerization assay.
Are U1C homodimers present in HeLa Ul snRNPs?
Assuming that dimerization of the human U1C protein has functional implications, it would be interesting to investigate whether U1C dimers are present in Ul snRNP particles as well. For the detection of U1C homodimers in Ul snRNPs, Ul particles were purified from HeLa cells as described by Bach et al. (30) and its protein components were separated on a reducing and a non-reducing SDS-polyacrylamide gel followed by Western blotting (Fig. 6) . Individual Ul snRNP proteins were visualized on the blot by immunostaining with monoclonal or monospecific antibodies specifically raised against particular UI snRNP proteins, except for Sm-E, as described previously (9) . Under reducing conditions the U1C protein was detected as a monomer migrating at a position of 21 kD. However, under non-reducing conditions not only U1C monomers were detected U1 snRNPs from HeLa cells with monospecific anti-UlC antibodies, but also a band of-42 kD which corresponds to the expected molecular weight of UIC homodimers (Fig. 6, lane 4) . Since none of the other antibodies stained a protein(complex) at the same position, these results suggest that UIC homodimers indeed are present in HeLa Ul snRNPs. Because the experiment was performed under conditions which are not favourable to interparticle interactions (22) the possibility of such interactions involving the UIC protein seems unlikely. We were not able to detect dimers in Ul snRNP particles purified from HeLa SI00 extract using sucrose gradient centrifugation (data not shown). We do not know whether U1C dimers are not present in this U1 snRNP population or that dimers have already been reduced to monomers due to the isolation and separation procedures.
DISCUSSION
Our results demonstrate that the human U1 snRNP-specific protein C is able to form homodimers. The finding that the residues between positions 22 and 30 within the CH-motif are necessary for dimerization, as shown in an in vitro dimerization assay and in the yeast two hybrid system, is in principle in agreement with the reported involvement of the two zinc finger-like motifs in the homodimerization of the yeast splicing factor PRP9 (13) . Legrain and co-workers observed in the yeast two hybrid system that homodimerization of PRP9, mutated in the conserved cysteine and histidine residues of the CH motif, was reduced with at least one order of magnitude. Our mutational analysis of the U1C zinc finger-like region in both our dimerization assay and the yeast two hybrid system showed that the amino acids between positions 22 and 30 are important for homodimerization. The conserved cysteines at positions 6 and 9 seem less important since deletion of the N-terminal 22 amino acids did not affect dimerization in the in vitro dimerization assay (Fig. 4) and the yeast two hybrid system (Fig. 5) . Further analyses of point mutants within the region between amino acids 22 and 30 of the U1C protein showed that the residues which previously had been indicated to be important for binding of the Ul snRNP particle (10), seem less important for homodimerization. Substitution of the conserved histidine residues in the CH motif (amino acids 24 and 30) hardly or only moderately affected the dimerization efficiency in our dimerization assay (Fig. 4B) . Based on these observations and the finding that dimers are stable under non-reducing SDS-PAGE conditions, we conclude that in vitro residue Cys-25 is likely to be involved in the formation of a disulfide bridge between two U1C molecules. This conclusion is in concert with data reported by Benezra (31) who showed that E2A proteins, a subfamily of the basic helix-loop-helix family of DNA-binding proteins, form homodimers that are linked via a disulfide bond. However, the appearance of relatively high monomer signals in our dimerization assay (Fig. 4B ) do indicate that non-covaJent interactions are involved in dimer formation as well.
We were also able to show the formation of U1C dimers with in vitro translated U1C. When a U1C translation mixture was separated by non-reducing SDS-PAGE no dimers were observed (Fig. 2, lane 2) . However, U1C dimers could be detected after immunoprecipitation with anti-UlC antibodies (Fig. 2, lane 3) . Since formation of dimers most likely depends on the concentration of the monomer protein, dimerization might be facilitated by binding of U1C to the bivalent antibodies. Alternatively, the binding of the antibodies could stimulate the U1C protein to adopt its native structure. Such antibody assisted protein folding has been demonstrated by Carlson and Yarmush for the ribonuclease A S-protein (32) . A third possibility is that the cell-free translation system contains a component that prevents dimer formation, as indeed has been suggested by Benezra (31) . By immunoprecipitation of U1C this component might be separated efficiently from the U1C protein.
Our data indicate that the U1C protein can form homodimers in vivo as well. This was shown in the yeast two hybrid assay (Fig.  5 ). Using this system the importance of the amino acids 23-29 of the U1C protein for dimer formation was corroborated. Indeed, the absolute values of P-galactosidase activity are low compared with those found for other homodimers detected with the yeast two hybrid assay, such as PRP9 (40 units, ref. 28) . Nevertheless, the positive results with the U1C protein were reproducibly found. It should be stressed that in the case of homodimerization, an inhibition of productive interactions may occur due to the formation of true homodimers between identical fusion proteins. The exact nature of the link between the two U1C monomers in vivo is not precisely known. In our in vitro experiments the formation of a disulfide bridge in addition to non-covalent interactions is necessary for the detection of U1C dimers after SDS-PAGE, as has been discussed above. In the yeast two hybrid system probably only non-covalent interactions between the two monomers exist as has been suggested by the positive results obtained with the U1C point mutants. But also in vivo such non-covalent interactions are primarily mediated by amino acid residues between positions 22 and 30.
The data shown in Figure 6 suggest that at least a considerable portion of the U1C protein from purified HeLa Ul snRNPs is present in dimers stabilized by a disulfide bridge. Part of the putative U1C dimers from HeLa Ul snRNPs may have been reduced during die preparation of the particles for which DTT-containing buffers were used (30) which may lead to an underrepresentation of dimers. We do not know whether the disulfide bridges are actually present in U1 snRNP particles or that they are formed during the snRNP isolation procedure. It is likely that the dimers are formed by non-covalent interactions which subsequently might facilitate the formation of a disulfide bridge. Our data are in agreement with the estimated stoichiometry for U1 snRNPs as proposed by Feeney et al. (33) who predicted the presence of two U1C molecules per U1 snRNP particle.
Since the U1C homodimer might be present in Ul snRNP particles in vivo, as suggested by the results of Figure 6 , an important question concerns the function of these U1C dimers. Data reported by Heinrichs et al. (7) indicated that the U1C protein is involved in the binding of the Ul snRNP particle to the pre-mRNA 5' splice site. Possibly, stable binding to the 5' splice site requires the presence of a U1C dimer on the Ul snRNP particle. Within such a model it can be speculated that UIC dimers are responsible for a direct contact widi the pre-mRNA. Our present studies are directed to test this hypothesis.
